TENAX THERAPEUTICS, INC. — Director's Dealing 2016

Dec 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2016-12-15

Reporting Person: Jebsen Michael B (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-15	Stock Option (right to buy)	$2.07	A	150000	Acquired	2026-12-15	Common Stock (150000)	Direct

Footnotes

F1: This option vests and becomes exercisable in four equal annual installments beginning on December 15, 2017.